Skip to content

iRadimed IRMD Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$86.28M+2.9%$83.81M+4.1%$80.51M+3.7%$77.64M+3.3%$75.15M+2.6%
$19.99M+2.6%$19.49M+5.6%$18.46M+3.2%$17.88M+3.1%$17.35M+2.7%
$66.3M+3.1%$64.32M+3.7%$62.05M+3.9%$59.75M+3.4%$57.81M+2.6%
76.8%+0.1pp76.7%-0.3pp77.1%+0.1pp77%0.0pp76.9%0.0pp
$3.31M+11.2%$2.97M+8.3%$2.75M+1.3%$2.71M+2.9%$2.64M-7.0%
$17.3M-0.7%$17.42M+0.5%$17.33M+5.1%$16.5M+3.3%$15.96M+2.2%
$17.74M-0.2%$17.78M+3.9%$17.12M+2.3%$16.73M+1.1%$16.56M+3.9%
$38.34M+0.4%$38.18M+2.6%$37.2M+3.5%$35.94M+2.2%$35.16M+2.2%
$38.34M+0.4%$38.18M+2.6%$37.2M+3.5%$35.94M+2.2%$35.16M+2.2%
$27.95M+6.9%$26.15M+5.2%$24.85M+4.4%$23.81M+5.1%$22.65M+3.1%
32.4%+1.2pp31.2%+0.3pp30.9%+0.2pp30.7%+0.5pp30.1%+0.1pp
$2.23M+0.9%$2.21M+7.4%$2.06M-7.4%$2.22M-4.4%$2.33M+0.8%
$30.18M+6.4%$28.36M+5.4%$26.91M+3.4%$26.03M+4.2%$24.98M+2.9%
$6.57M+11.8%$5.88M+2.6%$5.73M+6.6%$5.38M+3.6%$5.19M+3.0%
$23.61M+5.0%$22.48M+6.1%$21.18M+2.6%$20.66M+4.4%$19.78M+2.9%
27.4%+0.5pp26.8%+0.5pp26.3%-0.3pp26.6%+0.3pp26.3%+0.1pp
$1.83+4.6%$1.75+6.1%$1.65+1.9%$1.62+4.5%$1.55+3.3%
$1.86+5.1%$1.77+6.0%$1.67+2.5%$1.63+3.8%$1.57+2.6%
51.4M+0.1%51.4M+0.1%51.3M+0.2%51.2M+0.2%51.1M+0.1%
50.9M+0.1%50.9M+0.1%50.8M+0.1%50.8M+0.1%50.7M+0.1%
$27.95M+6.9%$26.15M+5.2%$24.85M+4.4%$23.81M+5.1%$22.65M+3.1%
$29.38M+7.6%$27.31M+5.7%$25.83M+5.0%$24.6M+5.0%$23.43M+2.9%
$29.38M+7.6%$27.31M+5.7%$25.83M+5.0%$24.6M+5.0%$23.43M+2.9%
34.1%+1.5pp32.6%+0.5pp32.1%+0.4pp31.7%+0.5pp31.2%+0.1pp
$27.95M+6.9%$26.15M+5.2%$24.85M+4.4%$23.81M+5.1%$22.65M+3.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is iRadimed's revenue?
iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.
Is iRadimed profitable?
iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.
What are iRadimed's profit margins?
Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.
What is iRadimed's earnings per share?
iRadimed's diluted EPS over the trailing twelve months is $1.83.
Where does iRadimed's income statement data come from?
Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.